Loading stock…

Astera Labs, Inc. (ALAB) Stock Verdict & Ratings | Investment Bastion

02Growth

Is it actually growing, and how fast?

ALABAstera Labs

Revenue FY25$853M

GROWTH RATING↗

VERY STRONG99 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+120%10

Revenue, next 1Y+124%10

Revenue, next 3Y, CAGR+66%10

Revenue, next 5Y, CAGR+25%10

EARNINGS FORECAST▾SCORE

EPS growth, FY26E+249%10

EPS growth, FY27E+59%9

EPS growth, FY28E+28%8

GROWTH ASSESSMENT

STRENGTHS

It out-grows 99% of companies worldwide.

Revenue grew 120%/yr over the last 3 years, ahead of 90% of companies worldwide.10/10

Revenue is set to grow 66%/yr over the next 3 years, ahead of most of the market.10/10

The runway holds up: revenue is set to grow 25%/yr over five years.10/10

WATCH

Revenue grew 120%/yr over the last 3 years; forecasts see it cooling to 66%/yr.

Earnings are set to grow slower than sales (EPS about 59%/yr vs revenue 66%/yr), so margins are under pressure.

WEAKNESSES

None flagged.

BOTTOM LINE

Elite Compounder

A top-tier grower that is slowing. The one thing to watch: the pace is cooling.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

VERY STRONG91 / 100

SHORT-TERM RETURNS▾SCORE

1-month return+26%10

3-month return+2%7

YTD return+134%10

MID & LONG-TERM▾SCORE

% of 52-week high78%5

1-year return+84%10

3-year return+528%10

5-year return+528%10

MOMENTUM ASSESSMENT

STRENGTHS

Magnificent long-term results. Long-term holders have seen +528% over three years and +528% over five, ahead of 90% of the market.

It's up 84% over the past year, but 22% below its 52-week high. That is clearly ahead of the market.

Strong recent results. The stock is outperforming over the past month (+26%), over three months (+2%) and so far this year (+134%).

WATCH

None flagged.

WEAKNESSES

None flagged.

BOTTOM LINE

Momentum Leader

Short- and long-term returns both rank among the best globally. The market is behind it — a core fit for momentum strategies.

04Value

Are you paying a fair price for it?

Stop guessing on Astera Labs. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Loading charts…

02Growth

Is it actually growing, and how fast?

ALABAstera Labs

Revenue FY25$853M

GROWTH RATING↗

VERY STRONG99 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+120%10

Revenue, next 1Y+124%10

Revenue, next 3Y, CAGR+66%10

Revenue, next 5Y, CAGR+25%10

EARNINGS FORECAST▾SCORE

EPS growth, FY26E+249%10

EPS growth, FY27E+59%9

EPS growth, FY28E+28%8

GROWTH ASSESSMENT

STRENGTHS

It out-grows 99% of companies worldwide.

Revenue grew 120%/yr over the last 3 years, ahead of 90% of companies worldwide.10/10

Revenue is set to grow 66%/yr over the next 3 years, ahead of most of the market.10/10

The runway holds up: revenue is set to grow 25%/yr over five years.10/10

WATCH

Revenue grew 120%/yr over the last 3 years; forecasts see it cooling to 66%/yr.

Earnings are set to grow slower than sales (EPS about 59%/yr vs revenue 66%/yr), so margins are under pressure.

WEAKNESSES

None flagged.

BOTTOM LINE

Elite Compounder

A top-tier grower that is slowing. The one thing to watch: the pace is cooling.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

VERY STRONG91 / 100

SHORT-TERM RETURNS▾SCORE

1-month return+26%10

3-month return+2%7

YTD return+134%10

MID & LONG-TERM▾SCORE

% of 52-week high78%5

1-year return+84%10

3-year return+528%10

5-year return+528%10

MOMENTUM ASSESSMENT

STRENGTHS

Magnificent long-term results. Long-term holders have seen +528% over three years and +528% over five, ahead of 90% of the market.

It's up 84% over the past year, but 22% below its 52-week high. That is clearly ahead of the market.

Strong recent results. The stock is outperforming over the past month (+26%), over three months (+2%) and so far this year (+134%).

WATCH

None flagged.

WEAKNESSES

None flagged.

BOTTOM LINE

Momentum Leader

Short- and long-term returns both rank among the best globally. The market is behind it — a core fit for momentum strategies.

04Value

Are you paying a fair price for it?

Stop guessing on Astera Labs. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Astera Labs, Inc.

01Key Ratings

02Growth

03Price Momentum

04Value

Stop guessing on Astera Labs. Get the full investment case.

Premium

02Growth

03Price Momentum

04Value

Stop guessing on Astera Labs. Get the full investment case.

Premium